BPH ENERGY LTD — Capital/Financing Update 2010

Jan 6, 2010

==> picture [197 x 85] intentionally omitted <==

BPH Corporate (ASX: BPH) ASX Announcement

7 January 2010

Companies Announcements Office Australian Securities Exchange Limited 10[th] Floor, 20 Bond Street Sydney NSW 2000

BPH Placement

BPH Corporate Limited (BPH) is pleased to advise that it has raised a further $1.9 million under the Second offer of its prospectus.

A total of 14,971,204 ordinary fully paid shares and 14,971,204 free attaching options were allotted and issued into the issuer sponsored sub register on 6 January 2010.

BPH would like to thank all participants of the First and Second Offers.

The Directors of BPH would also like to welcome all new shareholders to BPH.

Please find attached the shareholder distribution schedule detailing the 20 largest holders by each class and a distribution schedule of options setting out the number of holders in each category per item 36 of the Appendix 3B. An amended Appendix 3B has also been attached.

Yours faithfully,

==> picture [103 x 40] intentionally omitted <==

Deborah Ambrosini

Director and Company Secretary

BPH Corporate Limited ACN 95 912 002 PO Box 317, North Perth Western Australia 6906 14 View Street, North Perth Western Australia 6006 admin@biopharmica.com.au www.biopharmica.com.au

T: +61 8 9328 8366 F: +61 8 9328 8733

Security Transfer Registrars Pty Ltd/ BE/BE / / BIOPHARMICA LTD FULLY PAID Page - 1 HOLDER NAME DESIGNATION 1 MEC RES LTD 2 * TRANDCORP PL 3 * JOJO ENTPS PL SFI FAM A/C 4 * GRANDBRIDGE LTD 5 * IGO ANDY ADE S/F A/C 6 AVATAR EQUITIES PL AVATAR SHARE TRADI 7 * TRANDCORP PL D & J BREEZE SUPER 8 * CLAYMORE CAP PL 9 BOUNTY OIL & GAS NL 10 * TAYCOL NOM PL 11 BIOPHARMICA LTD PENDING ACCOUNT 12 GOLD MARQUEE ENTPS PL 13 SHARECHART PL 14 HOFFMAN CECIL + NORMA HOFFMAN S/F A/C 15 SUMPTER JIM + DALE E 16 DEAD KNICK PL 17 IPCONCEPT MGNT SA 18 TAN BIAU LUAN 19 GOH HOCK 20 GILBERT GREGORY *** TOP 20 TOTAL *** ** ALL HOLDERS INCLUDED * - DENOTES MERGED HO	SPREAD&	TOP	20 LISTING S T STATUS -* % OF ISSUED 11.27% 4.61% 4.25% 3.28% 2.57% 2.05% 1.54% 1.28% 1.23% 1.17% 1.06% .82% .77% .62% .52% .51% .51% .51% .46% .46 % 39.49 %	RSPTP USER - KAREN Date - 7/01/10 Time - 12.35.32 *- AS AT: 7/01/10 -* UNITS % OF ISSUED 23,318,379 11.27% 1 9,545,000 4.61% 2 8,803,401 4.25% 3 6,778,200 3.28% 4 5,314,626 2.57% 5 4,251,701 2.05% 6 3,183,852 1.54% 7 2,642,900 1.28% 8 2,551,020 1.23% 9 2,421,347 1.17% 10 2,194,000 1.06% 11 1,700,680 .82% 12 1,594,388 .77% 13 1,275,510 .62% 14 1,069,871 .52% 15 1,062,925 .51% 16 1,062,925 .51% 17 1,062,925 .51% 18 961,538 .46% 19 961,538 .46 % 20 81,756,726 39.49 %
	*- CURREN UNITS 23,318,379 9,545,000 8,803,401 6,778,200 5,314,626 4,251,701 3,183,852 2,642,900 2,551,020 2,421,347 2,194,000 1,700,680 1,594,388 1,275,510 1,069,871 1,062,925 1,062,925 1,062,925 961,538 961,538	CURREN UNITS
	81,756,726			81,756,726
	LDER

	Security Transfer Registrars Pty Ltd/ BE/BE BIOPHARMICA LTD FULLY PAID SPREADOF HOLDINGS HOLDERS NIL HOLDING 1 - 1,000 258 1,001 - 5,000 487 5,001 - 10,000 417 10,001 - 100,000 1248 100,001 -336 TOTAL ON REGISTER 2746 TOTAL OVERSEAS HOLDERS 45 ANALYSIS BY LOCATION (EXCLUDES ZERO HOLDERS) OVERSEAS 45 AUSTRALIA : ACT 63 NSW 906 VIC 620 QLD 371 SA 158 WA 446 TAS 30 NT 13 ADDRESS UNKNOWN94 2746	/ / UNITS 88,040 1,562,919 3,668,586 46,250,329 155,365,990 206,935,864 6,718,904 6,718,904 1,945,375 48,879,298 33,259,181 20,412,004 12,263,909 81,387,341 803,953 277,269 988,630 206,935,864	S	PR	EAD&	TOP 20 LISTING SRSPTP Page - 1 User - KAREN Date - 7/01/10 Time - 12.35.32 SUEDCAPITAL .04 % .76 % 1.77 % 22.35 % 75.08 % 100.00 % 3.25 % 3.25 % .94 % 23.62 % 16.07 % 9.86 % 5.93 % 39.33 % .39 % .13 % .48 % 100.00 %
				%	OF IS

  ** ALL HOLDERS INCLUDED                  ***  COMMON HOLDERS MERGED INTO ONE HOLDING

 Security Transfer Registrars Pty Ltd/ BA/BA           /  /
 BIOPHARMICA LIMITED OPTIONS EXPIRING 31 MAY 2010 $0.20              SPREAD & TOP  20 LISTING  SRSPTP    Page -    1         User - KAREN
                                                                                                         Date -  7/01/10     Time - 12.36.01

	SPREADOF HOLDINGS HOLDERS NIL HOLDING 1 - 1,000 3 1,001 - 5,000 25 5,001 - 10,000 42 10,001 - 100,000 171 100,001 - 158 TOTAL ON REGISTER399 TOTAL OVERSEAS HOLDERS 10 ANALYSIS BY LOCATION (EXCLUDES ZERO HOLDERS) OVERSEAS 10 AUSTRALIA : ACT 2 NSW 123 VIC 70 QLD 42 SA 48 WA 103 TAS 1 NT 0 ADDRESS UNKNOWN0 399	UNITS 2,800 92,400 389,006 7,645,027 102,824,301 110,953,534 5,952,381 5,952,381 90,000 25,201,398 16,093,427 8,615,822 9,438,852 45,476,620 85,034 110,953,534	%	OF IS	SUEDCAPITAL .00 % .08 % .35 % 6.89 % 92.67 % 100.00 % 5.36 % 5.36 % .08 % 22.71 % 14.50 % 7.77 % 8.51 % 40.99 % .08 % .00 % .00 % 100.00 %

  ** ALL HOLDERS INCLUDED                  ***  COMMON HOLDERS MERGED INTO ONE HOLDING

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.

Name of entity

Biopharmica Limited

ABN

41 095 912 002

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1 +Class of+securities issued or to be issued 2 Number of+securities issued or to be issued (if known) or maximum number which may be issued 3 Principal terms of the+securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)	Ordinary
	14,971,204 ordinary shares 14,971,204 listed options
	Ordinary shares Options – exercisable at 20c expiry date 31 May 2010

• See chapter 19 for defined terms.

24/10/2005 Appendix 3B Page 1

Appendix 3B New issue announcement

4 Do the[+] securities rank equally in Ordinary Shares ‐ Yes all respects from the date of allotment with an existing[+] class of quoted[+] securities? If the additional securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration $1,871,400 6 Purpose of the issue Placement funds raised (If issued as consideration for the acquisition of assets, clearly identify those assets) 7 Dates of entering +securities 6 January 2010 into uncertificated holdings or despatch of certificates Number +Class 8 Number and +class of all 206,935,246 Ordinary +securities quoted on ASX ( including the securities in clause 2 if applicable) 110,953,534 Options exercisable at 20c expiring 31 May 2010

• See chapter 19 for defined terms.

Appendix 3B Page 2

24/10/2005

Appendix 3B New issue announcement

9 Number and +class of all +securities not quoted on ASX (including the securities in clause 2 if applicable)	Number	+Class
	6,000,000 6,550,000 150,000 3,000,000	Options exercisable at 15c each expiring 31 December 2010 Options issued under the employee share option scheme Options issued under the employee share option scheme Options exercisable at 45c each expiring 31 December 2014

• 10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

Part 2 - Bonus issue or pro rata issue

• 11 Is security holder approval n/a required?

• 12 Is the issue renounceable or non‐ n/a renounceable?

• 13 Ratio in which the[+] securities n/a will be offered

• 14 +Class of +securities to which the n/a offer relates

• 15 +Record date to determine n/a entitlements

• See chapter 19 for defined terms.

24/10/2005 Appendix 3B Page 3

Appendix 3B New issue announcement

16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? 17 Policy for deciding entitlements in relation to fractions 18 Names of countries in which the entity has+security holders who will not be sent new issue documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. 19 Closing date for receipt of acceptances or renunciations 20 Names of any underwriters 21 Amount of any underwriting fee or commission 22 Names of any brokers to the issue 23 Fee or commission payable to the broker to the issue 24 Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of+security holders 25 If the issue is contingent on +security holders’ approval, the date of the meeting 26 Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled	n/a
	n/a
	n/a
	n/a
	n/a
	n/a
	n/a
	n/a
	n/a
	n/a
	n/a

• See chapter 19 for defined terms.

Appendix 3B Page 4

24/10/2005

Appendix 3B New issue announcement

27 If the entity has issued options, n/a and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders 28 Date rights trading will begin (if n/a applicable) 29 Date rights trading will end (if n/a applicable) 30 How do[+] security holders sell n/a their entitlements in full through a broker? 31 How do[+] security holders sell n/a part of their entitlements through a broker and accept for the balance? 32 How do +security holders n/a dispose of their entitlements (except by sale through a broker)? 33 +Despatch date n/a

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

• 34 Type of securities ( tick one )

• (a) ⌧ Securities described in Part 1

• (b) All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

• See chapter 19 for defined terms.

24/10/2005 Appendix 3B Page 5

Appendix 3B New issue announcement

Tick to indicate you are providing the information or documents

• 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 ‐ 1,000 1,001 ‐ 5,000 5,001 ‐ 10,000 10,001 ‐ 100,000 100,001 and over

• 37 A copy of any trust deed for the additional[+] securities

Entities that have ticked box 34(b)

38	Number of securities for which
	+quotation is sought
39	Class of +securities for which
	quotation is sought
40	Do the+securities rank equally in
	all respects from the date of
	allotment with an existing+class
	of quoted+securities?
	If the additional securities do not
	rank equally, please state:
	• the date from which they do
	• the extent to which they
	participate for the next
	dividend, (in the case of a
	trust, distribution) or interest
	payment
	• the extent to which they do
	not rank equally, other than in
	relation to the next dividend,
	distribution or interest
	payment

• See chapter 19 for defined terms.

Appendix 3B Page 6

24/10/2005

Appendix 3B New issue announcement

41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another security, clearly identify that other security)

Number +Class

42 Number and +class of all +securities quoted on ASX ( including the securities in clause 38)

Quotation agreement

• 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

• 2 We warrant the following to ASX.

• The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

• There is no reason why those[+] securities should not be granted +quotation.

• An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

• Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no‐one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

• If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

• 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

• See chapter 19 for defined terms.

24/10/2005 Appendix 3B Page 7

Appendix 3B New issue announcement

• 4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

==> picture [115 x 35] intentionally omitted <==

Sign here:

Date: 7 January 2010

(Director/Company secretary)

Print name: Deborah Ambrosini

• See chapter 19 for defined terms.

Appendix 3B Page 8

24/10/2005